Crossmark

Comparison of Ajmaline and Procainamide Provocation Tests in the Diagnosis of Brugada Syndrome

Crossref DOI link: https://doi.org/10.1016/j.jacep.2019.01.026

Published Print: 2019-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Cheung, Christopher C.

Mellor, Greg

Deyell, Marc W.

Ensam, Bode

Batchvarov, Velislav

Papadakis, Michael

Roberts, Jason D.

Leather, Richard

Sanatani, Shubhayan

Healey, Jeffrey S.

Chauhan, Vijay S.

Birnie, David H.

Champagne, Jean

Angaran, Paul

Klein, George J.

Yee, Raymond

Simpson, Christopher S.

Talajic, Mario

Gardner, Martin

Yeung-Lai-Wah, John A.

Chakrabarti, Santabhanu

Laksman, Zachary W.

Sharma, Sanjay

Behr, Elijah R.

Krahn, Andrew D.
Funding

Funding for this research was provided by:

Heart and Stroke Foundation of Canada

Heart and Stroke Foundation of Canada (G-13-0002775)

Heart and Stroke Foundation of Canada (G-14-0005732)
License Information

Text and Data Mining valid from 2019-04-01

Text and Data Mining valid from 2019-04-01

Version of Record valid from 2020-04-01
More Information

This article is maintained by: Elsevier

Article Title: Comparison of Ajmaline and Procainamide Provocation Tests in the Diagnosis of Brugada Syndrome

Journal Title: JACC: Clinical Electrophysiology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.jacep.2019.01.026

Content Type: article

Copyright: © 2019 by the American College of Cardiology Foundation. Published by Elsevier.